<DOC>
	<DOC>NCT00420615</DOC>
	<brief_summary>The purpose of this study is to evaluate the potential inhibitory effects of patupilone on metabolism using midazolam and omeprazole as the respective probe drugs.</brief_summary>
	<brief_title>Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Epothilone B</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Inclusion criteria: Male or female patients 18 years or older Histologically documented advanced solid tumor, who have failed standard systemic therapy, or for whom standard systemic therapy does not exist Life expectancy of 3 months or more Patients with adequate hematologic parameters Exclusion criteria: Hypersensitivity to midazolam or omeprazole or related compounds Female patients who are pregnant or breastfeeding. Patients with a severe and/or uncontrolled medical disease Patients with a known diagnosis of human immunodeficiency virus (HIV) infection Patients having received an investigational agent within 30 days prior to study entry Other protocol defined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Cancer</keyword>
	<keyword>EPO906</keyword>
	<keyword>Patupilone</keyword>
</DOC>